Upstream Bio (UPB) Receivables (2023 - 2025)
Historic Receivables for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $2.3 million.
- Upstream Bio's Receivables rose 11126.37% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 11126.37%. This contributed to the annual value of $1.2 million for FY2024, which is 40000.0% up from last year.
- According to the latest figures from Q3 2025, Upstream Bio's Receivables is $2.3 million, which was up 11126.37% from $2.6 million recorded in Q2 2025.
- Over the past 5 years, Upstream Bio's Receivables peaked at $2.6 million during Q2 2025, and registered a low of $236000.0 during Q4 2023.
- Moreover, its 3-year median value for Receivables was $1.2 million (2024), whereas its average is $1.4 million.
- Per our database at Business Quant, Upstream Bio's Receivables soared by 40000.0% in 2024 and then soared by 11126.37% in 2025.
- Upstream Bio's Receivables (Quarter) stood at $236000.0 in 2023, then soared by 400.0% to $1.2 million in 2024, then skyrocketed by 95.51% to $2.3 million in 2025.
- Its Receivables stands at $2.3 million for Q3 2025, versus $2.6 million for Q2 2025 and $1.7 million for Q1 2025.